- Home
- KNSA vs MRX Comparison
KNSA vs MRX Comparison
Compare KNSA & MRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- MRX
- Stock Information
- Founded
- KNSA 2015
- MRX 2005
- Country
- KNSA United Kingdom
- MRX United Kingdom
- Employees
- KNSA N/A
- MRX N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- MRX
- Sector
- KNSA Health Care
- MRX
- Exchange
- KNSA Nasdaq
- MRX NYSE
- Market Cap
- KNSA 1.7B
- MRX 1.6B
- IPO Year
- KNSA 2018
- MRX 2024
- Fundamental
- Price
- KNSA $26.79
- MRX $24.80
- Analyst Decision
- KNSA Strong Buy
- MRX Strong Buy
- Analyst Count
- KNSA 5
- MRX 7
- Target Price
- KNSA $33.60
- MRX $27.43
- AVG Volume (30 Days)
- KNSA 283.3K
- MRX 273.7K
- Earning Date
- KNSA 10-29-2024
- MRX 11-07-2024
- Dividend Yield
- KNSA N/A
- MRX 0.56%
- EPS Growth
- KNSA N/A
- MRX 291.43
- EPS
- KNSA N/A
- MRX 2.40
- Revenue
- KNSA $338,930,000.00
- MRX $2,081,600,000.00
- Revenue This Year
- KNSA $58.95
- MRX N/A
- Revenue Next Year
- KNSA $36.22
- MRX $3.95
- P/E Ratio
- KNSA N/A
- MRX $10.23
- Revenue Growth
- KNSA 20.69
- MRX 14.49
- 52 Week Low
- KNSA $14.12
- MRX $18.13
- 52 Week High
- KNSA $27.92
- MRX $26.80
- Technical
- Relative Strength Index (RSI)
- KNSA 58.67
- MRX N/A
- Support Level
- KNSA $23.33
- MRX N/A
- Resistance Level
- KNSA $27.35
- MRX N/A
- Average True Range (ATR)
- KNSA 0.89
- MRX 0.00
- MACD
- KNSA 0.15
- MRX 0.00
- Stochastic Oscillator
- KNSA 86.07
- MRX 0.00
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About MRX MAREX GROUP PLC
Marex Group PLC is a company that offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. It provides critical services to the clients by connecting them to global exchanges and providing a range of execution and hedging services across a range of its asset and products. They operate in a large and fragmented market with significant infrastructure requirements and regulatory and technological complexity, resulting in high barriers to entry.